MARIO MEJORADO, JR., MPA, CMR [email protected] • www.mariomejorado.com • 845.855.1999 h • 914.475.8265 c
PHARMACEUTICAL SPECIALTY SALES EXECUTIVE Strategic Leadership & Planning / Key Customer Relationships / Formulary Acceptance
High-performing pharmaceutical sales professional with 11 years of progressive success and stellar contributions in sales, market share and volume growth, and formulary pull-through experience. Recognized superb relationship manager, developing loyal customer base among PCP Physicians, Specialists and Mid-level Providers. Exceptional communication strengths, providing complex technical and scientific information accurately and concisely to individuals and audiences including cardiologists, endocrinologists and nephrologists. Solid strategic planning and territory management expertise coupled with proven ability to launch new products. Organized, analytical and resourceful; excellent trainer, team motivator and problem solver. Fluent in Spanish.
Sales and Relationship Management Strengths:
PROFESSIONAL EXPERIENCE
SANOFI-AVENTIS US – Bridgewater, NJ Executive Sales Professional (2002 to 2009) Assigned to develop market and maximize sales of Lantus & Apidra insulin products for diabetic market segment. Secured access to, established, cultivated and maximized decision-maker relationships among physicians, clinic administrators and/or practice managers, and other stakeholders to foster product sales, formulary acceptance / maintenance, and market expansion. Ensured product availability and smooth delivery. Planned, organized, and executed educational symposia, presenting complex technical and scientific information to advance customer knowledge of and familiarity with products. Responded to inquiries from physicians and others at appropriate level. Compiled and analyzed market statistics to identify and seize sales opportunities. Defined goals and crafted effective strategies to achieve targets; coordinated across functions to maximize sales abilities. Trained and coached new hires. Selected Contributions:
Secured Lantus market share of 55.1%, TRX share growth of 3.8%, TRX volume growth of 14.4%(2008).
Achieved Lantus NRX volume growth of 16. %, NRX share growth of 6. % in 2008.
Regional Sales Champion Award Winner, 2007; finished 4th in region.
Regional Sales Champion Award Winner, 2006; finished 2nd in region and 84th nationally.
Finished 3rd in nation with Apidra Market Share of 12.34% (3/519).
First in region with Apidra market share change of 5.9% in 2nd half of 2006 and top 10 nationally.
Sales achievement of 103.8% for Lantus 2nd half 2006 and 102.8 % for first half of 2006.
Attained Lantus market share change of 7.8% in 2006; first in region.
Drove market share increases for Lantus of 9.3% (2003), 8.8% (2005), 7.8% (2004) and 4.3% (2003) -earning multiple awards and recognition for maximizing sales and market share.
Recognized for driving Amaryl sales for 5 months throughout Northeast Region in 2003, achieving111% of goals along with 4.6% market share increase. MARIO MEJORADO, JR. • Page 2
Assigned to direct Danbury Hospital and Stamford Hospital Center Residency Programs in 2003.
Secured numerous performance awards, including MVP Award, Salesmanship Award, MostPrescriber Award (Apidra Blitz Contest), Fast Start Q4 Big Finish Award, Run for November Award.
Successfully leveraged community and professional organization participation to improve company’spublic image and market awareness.
ASTRAZENECA – Providence, RI Pharmaceutical Sales Specialist III (2001 to 2002) Pharmaceutical Sales Specialist II (2000 to 2001) Accessed, established relationships with and managed sales among physicians, specialists, and executives in clinical and hospital environments. Gathered, analyzed and leveraged data to maximize market-share growth and identify territory area as well as develop budgets and define optimal call frequency. Assimilated and utilized extensive technical and scientific information to provide product knowledge and guidance to customer base; resolved problems within required guidelines and adhered to regulatory requirements. Compiled and reported on sales metrics; mentored colleagues. Selected Contributions:
Selected by regional managers to launch and manage new drug-sales training program, serving asCrestor Training Captain and coaching 6 sales professionals.
Achieved Sales Value Proposition Award following development of cardiovascular benchmarkassessment study notes program, subsequently adopted at regional level.
Drove 123% of plan for Atacand, 105% for Toprol-XL, and 101% for Zestril / Zestoretic during FY2000.
PROFESSIONAL DETAILING INC. – Upper Saddle River, NJ Sales Representative (1998 to 2000) Managed 4-county territory, developing and managing sales strategies along with cultivating strong relationships with PCPs and specialists. Developed and delivered presentations on and promoted Atacand (candestartan cilexetil) and Prilosec (omeprazole). Served as district field trainer. Selected Contribution:
Achieved 104% of targeted sales for assigned drug in 1999. Additional Experience: Major / National Account Executive, Sprint PCS, Wallingford, CT; Associate Territory Business Manager, Innovex, Inc. , Parsippany, NJ; Sales Representative, Hilti, Inc. , Tulsa, OK; AccountRepresentative, A-Copy Inc-Alco Standard, Milford, CT; District Manager, Automatic Data Processing, Milford, CTEDUCATION AND CREDENTIALS Master of Public Administration (MPA), 2002 • PACE UNIVERSITY –White Plains, NY Thesis: Heart Failure in the United States & Impact on the Healthcare System ~ GPA 3.69 Bachelor of Arts • UNIVERSITY OF MARYLAND – College Park, MD Certifications: Certified Medical Representative, 2007- The Certified Medical Representative Institute, Inc., Roanoke, VA Continuing Education: The Value of Pharmaceuticals, Business & Strategic Planning, Managing Business Communication, Business & Management Strategies in Healthcare, Business Healthcare, Sanofi-Aventis Pharmaceuticals Advanced / Basic Sales, AstraZeneca Core I& II, Bristol-Myers Squibb Phase I & II Therapeutic & Sales Course and numerous additional employer-specific sales courses.
AMWAY SEES NUTRILITE SALES SURGING 150% NEXT YEAR Amway India, on Tuesday announced its entry into the kids' nutritional category by launching five products under Nutrilite. "Nutrilite will easily cross `1,000 crore by the end of this year. With the launch of the new products, we are targeting sales of `2,500 crore from the brand by 2012," Amway India managing director and chief execut